Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study comparing BOTOX versus Xeomin for blepharospasm
2005-006170-10Phase 4Completed
- Sponsor
- Allergan
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in idiopathic blepharospasm (BEB) (2 arms), sponsored by Allergan. Primary endpoint: Change from baseline in severity of Jankovic Rating Scale at Week 4. Started Mar 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on 2005-006170-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006170-10.